1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HERC3 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA FAM69A CTRPv2 pan-cancer AAC -0.093 0.01
mRNA NELFE CTRPv2 pan-cancer AAC -0.09 0.01
mRNA SIX4 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA C6orf222 CTRPv2 pan-cancer AAC 0.098 0.01
mRNA HAT1 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA YY2 CTRPv2 pan-cancer AAC -0.095 0.01
mRNA TXLNB CTRPv2 pan-cancer AAC -0.094 0.01
mRNA IDI2 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA SLC25A35 CTRPv2 pan-cancer AAC -0.09 0.01
Download CSV